Bio Essence Corp
BIOE· OTC
Filed May 12, 2023 · 10-Q · 42 days after period end · 0001213900-23-039043
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $341.33K | $306.41K | $212.03K | $306.35K |
| Net Income | -$178.84K | -$233.12K | -$210.36K | -$117.14K |
| EPS Diluted | -$0.01 | -$0.01 | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Essence Corp · CIK 1723059 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 12, 2023 · 42 d after period end